Your browser doesn't support javascript.
loading
Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2).
Sackeim, Harold A; Aaronson, Scott T; Bunker, Mark T; Conway, Charles R; George, Mark S; McAlister-Williams, R Hamish; Prudic, Joan; Thase, Michael E; Young, Allan H; Rush, A John.
Afiliación
  • Sackeim HA; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, USA. Electronic address: has1@columbia.edu.
  • Aaronson ST; Sheppard Pratt Health System and Department of Psychiatry, University of Maryland, Baltimore, MD, USA.
  • Bunker MT; LivaNova PLC, Houston, TX, USA.
  • Conway CR; Department of Psychiatry, Washington University, St. Louis, MO, USA.
  • George MS; Departments of Psychiatry,Neurology,and Neuroscience, Medical University of South Carolina and Ralph H. Johnson VA Medical Center, Charleston, SC, USA.
  • McAlister-Williams RH; Northern Centre for Mood Disorders, Translational and Clinical Research Institute, Newcastle University, UK; Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Prudic J; New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York, NY, USA.
  • Thase ME; Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
  • Young AH; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, and South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Beckenham, UK.
  • Rush AJ; Duke-NUS Medical School, Singapore; Duke University, Durham, NC, USA; Texas Tech University, Permian Basin, TX, USA.
J Psychiatr Res ; 176: 325-337, 2024 Aug.
Article en En | MEDLINE | ID: mdl-38917723
ABSTRACT
All definitions of treatment-resistant depression (TRD) require that patients have experienced insufficient benefit from one or more adequate antidepressant trials. Thus, identifying "failed, adequate trials" is key to the assessment of TRD. The Antidepressant Treatment History Form (ATHF) was one of the first and most widely used instruments that provided objective criteria in making these assessments. The original ATHF was updated in 2018 to the ATHF-SF, changing to a checklist format for scoring, and including specific pharmacotherapy, brain stimulation, and psychotherapy interventions as potentially adequate antidepressant treatments. The ATHF-SF2, presented here, is based on the consensus of the ATHF workgroup about the novel interventions introduced since the last revision and which should/should not be considered effective treatments for major depressive episodes. This document describes the rationale for these choices and, for each intervention, the minimal criteria for determining the adequacy of treatment administration. The Supplementary Material that accompanies this article provide the Scoring Checklist, Data Collection Forms (current episode and composite of previous episodes), and Instruction Manual for the ATHF-SF2.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Depresivo Resistente al Tratamiento / Antidepresivos Límite: Humans Idioma: En Revista: J Psychiatr Res Año: 2024 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Depresivo Resistente al Tratamiento / Antidepresivos Límite: Humans Idioma: En Revista: J Psychiatr Res Año: 2024 Tipo del documento: Article Pais de publicación: Reino Unido